Showing results (451-460 of 471) with videos related to
Sort By:
Pageof 48
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitorsKaren A Atkinson, Elena E Beretta, Janice A Brown, et al.Gynecologic Oncology Reports|September 2, 2025
Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinomaJulia Chalif, Molly Morton, Eric McLaughlin, et al.Gynecologic Oncology|July 15, 2026
Outcomes following complete response to immune checkpoint inhibitors in endometrial cancerReed M O'Connor, Julia Chalif, Anna Gonzalez, et al.Journal of Neurology|August 30, 2018
Correlation of phenotype with genotype and protein structure in RYR1-related disordersJoshua J Todd, Vatsala Sagar, Tokunbor A Lawal, et al.American Journal of Obstetrics and Gynecology|August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancerMichelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.Gynecologic Oncology|April 10, 2023
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomesMonica D Levine, David A Barrington, Caitlin E Meade, et al.Obesity (Silver Spring, Md.)|November 4, 2024
Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight lossAshley S Felix, Jennifer A Sinnott, Bette J Caan, et al.Gynecologic Oncology|May 27, 2026
Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinomaCassidy S Abdeen, Reed M O'Connor, Julia Chalif, et al.Journal of the National Cancer Institute|November 21, 2017
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional CharacterizationChristopher J Walker, Craig M Rush, Paola Dama, et al.Gynecologic Oncology|July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survivalCasey M Cosgrove, David E Cohn, Heather Hampel, et al.Pageof 48